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Purpose: We conducted a retrospective cohort study to determine incidences of transient and 
persistent acute kidney injury (AKI) after major abdominal surgery and their impacts on 
long-term outcome. 
Materials and Methods: We enrolled 3,751 patients undergoing major abdominal surgery. 
Postoperative AKI was classified as transient or persistent based on the return of serum 
creatinine to the non-AKI range within 7 days post-surgery. Primary outcome was mortality 
within 1 year. We used multivariable Cox proportional hazard regression analysis to assess 
independent associations between AKI type and mortality. 
Results: Most patients with AKI were classified as transient (84%). Compared to patients 
without AKI, both patients with transient and persistent AKI demonstrated elevated 1-year 
mortality rates [adjusted hazard ratio (95% confidence interval): 2.01 (1.34–2.93); P = 0.001, 
and 6.20 (3.00–11.43); P < 0.001, respectively] and greater risk of chronic kidney disease 
progression at 1 year [adjusted odds ratio (95% confidence interval): 3.87 (2.12–7.08) and 
23.70 (9.64–58.22), respectively; both P < 0.001]. 
Conclusions: Although most AKI cases after major abdominal surgery recover completely 
within 7 days, even these patients with transient AKI are at higher risk for 1-year mortality 
and chronic kidney disease progression compared to patients without AKI.  
 






Acute kidney injury (AKI) is a leading cause of perioperative morbidity and mortality. It 
occurs in 6%–13% of patients undergoing non-cardiac surgery [1–3] and is associated with 
higher mortality [4,5]. Moreover, AKI is associated with an increased risk of chronic kidney 
disease (CKD) development or CKD progression in various clinical settings [6–11]. 
In our clinical experience, postoperative AKI is often transient. It has been suggested that 
transient AKI represents a temporary reduction in glomerular filtration rate without structural 
kidney injury, whereas persistent AKI reflects structural renal tubular damage [12]. However, 
recent studies in hospitalized patients have found that even transient AKI is associated with 
long-term morbidity and mortality [13–15].  
To date, few studies have evaluated the incidence of transient AKI after non-cardiac surgery 
[16], and the prognostic value of transient AKI in non-cardiac surgery patients is not well 
validated. Moreover, the impact of transient AKI on long-term kidney function is not known. 
Revealing the incidence of transient AKI and its impact on outcome in surgical populations 
may help identify patients with poor postoperative course and provide appropriate treatment 
alternatives. 
Therefore, we conducted a retrospective cohort study to determine the incidence and impact 
on long-term outcomes of transient and persistent AKI after major abdominal surgery. We 
hypothesized that the majority of AKI after major abdominal surgery would be transient. In 
addition, we investigated the associations between AKI type and subsequent long-term 




2. Materials and Methods 
2.1 Study design, setting, and patients 
We conducted a single-center retrospective cohort study at Kyoto University Hospital, an 
1,121-bed teaching hospital in Japan. The study protocol was approved by the Ethics 
Committee of Kyoto University Hospital (approval number: R0672, July 26th, 2016), and the 
requirement for informed consent was waived. This article adheres to the Strengthening the 
Reporting of Observational Studies in Epidemiology guidelines [17]. We recruited patients 
using the database created for our previous study investigating the relationship between 
intraoperative oliguria and AKI after major abdominal surgery [18]. Patients 18 years or older 
who underwent major abdominal surgery (liver, colorectal, gastric, pancreatic, or esophageal 
resection) under general anesthesia at Kyoto University Hospital from March 2008 to April 
2015 were eligible for inclusion. Exclusion criteria included concurrent cardiac or urological 
procedures and patients with end-stage renal disease [i.e., estimated glomerular filtration rate 
(eGFR) < 15 mL/min/1.73 m2 as determined using a formula validated in Japan [19] or a 
receipt of hemodialysis]. We also excluded patients who died within 7 days of surgery 
because mortality in these cases appeared unrelated to AKI, and assessing the incidences of 
transient and persistent AKI or their impacts on subsequent outcomes are not relevant in this 
population. 
 
2.2 Data collection 
The research database for our previous study [18] included age, sex, preoperative 
comorbidities, American Society of Anesthesiologists Physical Status, preoperative serum 
creatinine (SCr) (the most recent SCr level measured before surgery), type of surgery, SCr 
during the 7 days after surgery, postoperative length of hospital stay, and in-hospital 
mortality. In addition, data on survival time during the year after surgery and SCr at 3 months 
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and 1 year post-surgery were collected from the electronic medical record system. 
2.3 Outcomes and exposure 
The primary outcome was mortality during 1-year follow-up. Secondary outcomes included 
in-hospital mortality, hospital length of stay, and CKD progression at 3 months and 1 year 
after surgery. CKD progression was defined as worsening of eGFR category (stage 1, ≥ 90 
ml/min/1.73 m2; stage 2, 60–89 ml/min/1.73 m2; stage 3a, 45–59 ml/min/1.73 m2; stage 3b, 
30–44 ml/ min/1.73 m2; stage 4, 15–29 ml/min/1.73 m2; and stage 5, <15 ml/min/1.73 m2) 
coupled with a ≥25% reduction in eGFR from baseline according to the Kidney Disease: 
Improving Global Outcomes 2012 Clinical Practice Guideline for the Evaluation and 
Management of Chronic Kidney Disease [20]. We calculated eGFR at 3 months and 1 year 
using the lowest SCr measured at postoperative days 8–90 and postoperative days 276–365, 
respectively. If SCr was not measured during these periods, the first value measured after the 
indicated period was used. 
The exposure of interest was AKI type (transient or persistent). AKI was defined as any stage 
of AKI according to the Kidney Disease: Improving Global Outcomes guidelines [21]. The 
AKI stages were based on the SCr concentration measured during the 7 days after surgery. 
Preoperative SCr was considered as the baseline. Transient AKI was defined as SCr values 
returning to below the AKI range within the first 7 days after surgery and persistent AKI as 
incomplete reduction of SCr at 7 days after surgery. This assessment window of 7 days was 
chosen because SCr levels fall below the AKI range within 7 days in the majority of patients 
with AKI and it may allow for comparison with previous studies [16,22]. 
 
2.4 Statistical analyses 
Continuous variables are presented as median [interquartile range] and compared using the 
Mann–Whitney U test. Categorical variables are presented as numbers (percentage) and 
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compared using the Pearson chi-square test or Fisher exact test as appropriate. Competing 
risk analysis was used to compare length of hospital stay between groups. Median length of 
hospital stay and 95% confidence intervals (CIs) were obtained using the cumulative 
incidence estimates of discharge while alive accounting for death as a competing risk, and 
Gray’s test was used to assess differences between groups. Survival was plotted on Kaplan–
Meier curves and compared between groups by the log-rank test. Moreover, Cox proportional 
hazard regression analysis was performed to investigate the independent relationship between 
AKI type and risk of death during 1-year follow-up. The following variables were included in 
the multivariable model based on clinical relevance: age, sex, preoperative comorbidities 
(hypertension, diabetes mellitus, CKD, and active congestive heart failure), type of surgery, 
emergency status, duration of surgery, intraoperative blood loss, and the need for 
intraoperative vasopressor infusion. CKD was defined as a preoperative eGFR level of <60 
ml/min/1.73 m2. Multivariable logistic regression analysis was performed to assess the 
independent relationship between AKI type and CKD progression among patients with 1-year 
survival. On the basis of clinical relevance and a literature search for factors associated with 
CKD and its progression [23], seven variables [age, sex, body mass index, preoperative 
comorbidities (hypertension, diabetes mellitus, and active congestive heart failure), and 
preoperative eGFR] were included in the multivariable model. Moreover, the adjusted hazard 
ratio for mortality and adjusted odds ratio for CKD progression at 1 year was assessed after 
stratifying based on the maximal AKI stage. 
All eligible patients in the study database were included to maximize statistical power. Our 
study database included approximately 3,800 eligible surgeries, and we assumed 1-year 
mortality after abdominal surgery to be 5%–6% on the basis of a published report [24]. We 
estimated that approximately 20 variables could be included in the Cox proportional hazard 
regression analysis using our dataset. We planned to conduct a complete patient analysis 
7 
 
including only patients with complete data on all variables required for multivariable 
analyses. Such an analysis is feasible only if <5% of patients have missing data [25]. Our 
data set fulfilled this criterion. 
All statistical tests were two tailed, and a P value of < 0.05 was considered statistically 






3.1 Baseline characteristics 
Figure 1 shows the flow diagram of this study. A total of 3,804 index major abdominal 
surgeries were identified in the study database. After excluding 39 patients with end-stage 
renal disease preoperatively and 6 patients who died within 7 days postoperatively, 3,759 
patients were eligible for the study. Among these patients, 8 (0.2%) had missing data on 
variables required for multivariable analyses. Patients with missing values accounted for less 
than 5%, so we conducted complete patient analysis including 3,751 patients. 
The median age of the study participants was 66 years [interquartile range: 56–73] and 2,323 
patients (61.9%) were male. AKI occurred in 258 patients (6.9%) of which 216 (5.8%) were 
classified as transient and 42 (1.1%) as persistent. Table 1 shows the preoperative patient 
characteristics and operative variables stratified by AKI type. Patients who developed AKI 
had a higher AKI risk index, more blood loss, and were more likely to receive intraoperative 
red blood cell transfusion and intraoperative vasopressor infusion. There were no statistically 
significant differences in clinical variables between patients with transient and persistent AKI 
except that patients with persistent AKI were younger than those with transient AKI. Table 2 
shows maximal AKI stage stratified by AKI type. The maximal AKI stage was lower in 
patients with transient AKI (of which 89.4% were in stage 1). 
 
3.2 Clinical events according to AKI type 
Clinical events during the 1-year follow-up are listed in Table 3. Patients with AKI (both 
transient and persistent) showed higher in-hospital mortality, longer length of hospital stay, 
higher mortality at 3 months and 1 year post-surgery, and more frequent CKD progression at 
3 months and 1 year post-surgery than patients without AKI. Kaplan−Meier curve analysis 
revealed significantly higher death rates in both transient and persistent AKI groups 
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compared to patients without AKI (P < 0.001 for both comparisons; Figure 2). Survival 
probabilities at 1 year were 94.6% (93.8%–95.4%) for patients without AKI, 83.7% (77.8%–
88.1%) for those with transient AKI, and 74.5% (57.6%–85.5%) for those with persistent 
AKI. Multivariable Cox proportional hazard regression analysis revealed that both transient 
and persistent AKI independently associated with higher mortality rate during 1-year follow-
up even after adjustment for confounders [adjusted hazard ratio (95% CI) for transient AKI: 
2.01 (1.34–2.93), P = 0.001; adjusted hazard ratio (95% CI) for persistent AKI: 6.20 (3.00–
11.43), P < 0.001] (Table 4). The association between transient/persistent AKI and mortality 
was found to be qualitatively preserved when stratified by the maximal AKI stage 
(Supplementary Table 1). 
 
3.3 Associations between AKI type and CKD progression at 1 year 
Among the 1-year survivors, 3.2% exhibited CKD progression at 1 year (Table 3). Most 
(77.8%) of the patients with CKD progression demonstrated reduced eGFR level by one 
eGFR category. Four patients developed CKD stage 5 at 1 year; all these patients had CKD 
stage 4 preoperatively (Supplementary Table 2). Multivariable logistic regression analysis 
revealed that both transient and persistent AKI were independently associated with CKD 
progression at 1 year after adjustment for known risk factors [adjusted odds ratio (95% CI) 
for transient AKI: 3.87 (2.12–7.08), P < 0.001; adjusted odds ratio (95% CI) for persistent 
AKI: 23.70 (9.64–58.22), P < 0.001] (Table 5). The association between transient/persistent 
AKI and CKD progression at 1 year was qualitatively preserved when stratified by the 





Of the 258 patients exhibiting AKI after major abdominal surgery, 84% were classified as 
transient according to the return of SCr value to the non-AKI range within the first 7 days 
post-surgery. However, like persistent AKI patients, these transient AKI patients 
demonstrated higher in-hospital mortality, longer hospital stay, and higher mortality rate 
during 1-year follow-up than non-AKI patients. Moreover, both transient and persistent AKI 
were associated with higher risk of CKD progression at 1 year independent of known risk 
factors for CKD and its progression. These data suggest that even temporary AKI after major 
abdominal surgery can increase the risk of mortality and CKD progression. Therefore, 
patients with AKI require careful follow-up even if SCr values return to the non-AKI range 
shortly after surgery. 
Of those patients exhibiting postoperative AKI following major abdominal surgery, the vast 
majority (84%) recovered completely within 7 days of surgery. This result is consistent with a 
previous study in which 90% of patients with AKI after gastric resection exhibited full renal 
recovery within 7 days [16]. In contrast, full renal recovery within 7 days has been reported 
in only 43%–65% of hospitalized patients who develop AKI [13–15]. This discrepancy may 
be explained by differences in the pathophysiology of AKI between hospitalized patients and 
postoperative patients. For instance, the most common causes of AKI in hospitalized patients 
include sepsis and heart failure [26, 27]. In contrast, the intraoperative period is unique in that 
both anesthesia and surgery combine to affect renal function [28]. 
To the best of our knowledge, this is the first study demonstrating that postoperative transient 
AKI is associated with CKD progression in patients undergoing non-cardiac surgery. A recent 
meta-analysis reported the association between the duration of AKI and outcomes including 
long-term mortality and incident CKD [29]. However, only two studies included in this 
systematic review reported on the risk for CKD in association with the duration of AKI; of 
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these, one study reported that even transient AKI is associated with CKD development in 
hospitalized patients [30], whereas the other study targeted patients undergoing cardiac 
surgery but was underpowered to assess the impact of transient AKI on CKD development 
[31]. Kim et al. [16] reported that postoperative transient AKI after gastric surgery was 
associated with higher long-term mortality; however, postoperative transient AKI was not 
associated with CKD development in their study, in contrast to the results of our study. There 
are several possible explanations for this apparent inconsistency. First, our study included 
patients with preoperative CKD, whereas the study by Kim et al. included only patients with 
normal preoperative renal function. The impact of transient AKI on CKD progression may be 
less severe in patients with normal preoperative renal function compared to those with 
preoperative renal dysfunction. Second, we used CKD progression to assess deterioration of 
renal function, whereas the study by Kim et al. used new CKD development. These 
difference in outcome definitions may contribute to the discrepancy in results.  
Early detection of CKD progression is extremely important because CKD-associated 
complications and progression to kidney failure can be delayed or even prevented through 
early introduction of appropriate interventions, including blood pressure and glycemic control 
[20]. Our data that postoperative transient AKI is associated with CKD progression suggest 
that even patients with transient AKI are at higher risk of CKD progression, and therefore 
require careful follow-up and may benefit from interventions to prevent CKD progression 
even after complete recovery of renal function. One possible explanation for this association 
with CKD progression is that many patients with transient AKI have structural kidney injury 
despite complete recovery of SCr. Alternatively, AKI may enhance the vulnerability to 
subsequent CKD due to other factors, such as hypertension and hyperglycemia.  
As expected, persistent AKI was more strongly associated with outcomes including CKD 
progression and long-term survival than transient AKI. These data suggest that early 
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identification of AKI and intensive treatment aimed at early recovery of renal function may 
benefit patients with postoperative AKI, although verification by future studies is required. 
Limitations of our study are as follows. This was a single-center study, which may reduce the 
generalizability of our results. Our study included patients undergoing major abdominal 
surgery, so it is unclear whether our findings can be extrapolated to patients undergoing other 
surgeries. Considering the study design, effects of unmeasured confounding variables on the 
observed associations cannot be ruled out, despite of our best efforts to adjust for 
confounding factors. For example, data on albuminuria/proteinuria, the use of nephrotoxins, 
the use of angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers, and 
the etiology of AKI for the enrolled patients were not available. Serum creatinine was not 
measured every day during the 7 days after surgery in all patients, so the incidence of 
transient AKI may have been underestimated. Nevertheless, the incidence of transient AKI in 
our study was as high as 84%. Finally, although an assessment window of 7 days was 
selected to distinguish between transient and persistent AKI, previous studies have applied 
different thresholds for determining the duration of AKI. Recently, the Acute Disease Quality 
Initiative proposed a definition of persistent AKI as the continuance of AKI beyond 48 h 







Although most patients with postoperative AKI after major abdominal surgery completely 
recover within the first 7 days, even patients with transient AKI are at higher risk for long-
term mortality and CKD progression compared to those without AKI. Patients with AKI 
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Table 1. Patient characteristics and operative variables 
  
All patients (n = 
3,751) 
No AKI (n = 3,493) 
Transient AKI 
(n = 216) 
Persistent AKI 
(n = 42) 
P-value 
Age (years) 66 [56–73] 66 [56–73] 67 [61–74]* 62 [57–69]† 0.010 
Male sex 2,323 (61.9%) 2,112 (60.5%) 176 (81.5%)* 35 (83.3%)* <0.001 
Hypertension 1,163 (31.0%) 1,026 (29.4%) 112 (51.9%)* 25 (59.5%)* <0.001 
Diabetes mellitus 617 (16.4%) 547 (15.7%) 54 (25.0%)* 16 (38.1%)* <0.001 
Active congestive heart failure 63 (1.7%) 53 (1.5%) 9 (4.2%)* 1 (2.4%) 0.012 
Ascites 311 (8.3%) 282 (8.1%) 21 (9.7%) 8 (19.1%)* 0.028 
ASA-PS (1/2/3/4/missing) 1026/2432/248/6/39 1010/2224/219/3/37 14/172/25/3/2* 2/36/4/0/0* <0.001 
Preoperative SCr (mg/dL) 0.7 [0.6–0.9] 0.7 [0.6–0.9] 0.8 [0.7–1.0]* 0.8 [0.6–0.9] <0.001 
Preoperative eGFR (mL/min/1.73 m2) 75.1 [63.8–87.7] 75.4 [64.1–87.9] 71.6 [56.0–85.4]* 75.4 [66.5–88.2] <0.001 
AKI risk index   * * <0.001 
   Class 1 1,319 (35.2%) 1,286 (36.8%) 29 (13.4%) 4 (9.5%)  
   Class 2 1,229 (32.8%) 1,158 (33.2%) 62 (28.7%) 9 (21.4%)  
   Class 3 804 (21.4%) 713 (20.4%) 75 (34.7%) 16 (38.1%)  
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   Class 4 309 (8.2%) 263 (7.5%) 34 (15.7%) 12 (28.6%)  
   Class 5 90 (2.4%) 73 (2.1%) 16 (7.4%) 1 (2.4%)  
Type of surgery   *  <0.001 
   Liver 1,189 (31.7%) 1,079 (30.9%) 93 (43.1%) 17 (40.5%)  
   Colorectal 1,105 (29.5%) 1,053 (30.2%) 42 (19.4%) 10 (23.8%)  
   Gastric 665 (17.7%) 627 (18.0%) 27 (12.5%) 11 (26.2%)  
   Pancreatic 554 (14.8%) 510 (14.6%) 41 (19.0%) 3 (7.1%)  
   Oesophageal 207 (5.5%) 197 (5.6%) 9 (4.2%) 1 (2.4%)  
   Complex 31 (0.8%) 27 (0.8%) 4 (1.9%) 0 (0.0%)  
Laparoscopic surgery 1,965 (52.4%) 1,888 (54.1%) 59 (27.3%)* 18 (42.9%) <0.001 
Emergency surgery 44 (1.2%) 39 (1.1%) 5 (2.3%) 0 (0.0%) 0.221 
Epidural anaesthesia 1,798 (47.9%) 1,657 (47.4%) 122 (56.5%)* 19 (45.2%) 0.034 
Duration of surgery (min) 353 [259–473] 347 [256–465] 444 [340–595]* 446 [315–544]* <0.001 
Intraoperative blood loss (mL) 150 [30–515] 132 [28–460] 783 [216–1575]* 621 [86–1602]* <0.001 
Net fluid balance during the surgery (mL) 2543 [1831–3487] 2505 [1815–3449] 3131 [2259–4319]* 3274 [2402–4053]* <0.001 
Intraoperative red blood cell transfusion 328 (8.7%) 256 (7.3%) 63 (29.2%)* 9 (21.4%)* <0.001 
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Intraoperative vasopressor infusion 343 (9.1%) 289 (8.3%) 44 (20.4%)* 10 (23.8%)* <0.001 
Data are presented as median [interquartile range] or numbers (percentages). *, P < 0.017 (significantly different with Bonferroni correction), 
compared with patients without AKI; †, P < 0.017 (significantly different with Bonferroni correction), compared with patients with transient AKI; 





Table 2. Maximal AKI stage stratified by AKI type 
Maximal AKI stage 
Transient AKI 
(n = 216) 
Persistent AKI 
(n = 42) 
Stage 1 193 (89.4%) 22 (52.4%) 
Stage 2 18 (8.3%) 12 (28.6%) 
Stage 3 5 (2.3%) 8 (19.1%) 




Table 3. Clinical outcomes according to AKI type 
 All patients No AKI Transient AKI Persistent AKI P-value 
In-hospital mortality 42/3,750 (1.1%) 27/3,492 (0.8%) 9/216 (4.2%)* 6/42 (14.3%)*† <0.001 
Hospital length of stay (days) 16 (16–16) 16 (15–16) 27 (23–30)* 38 (21–74)* <0.001 
3-month mortality 41/3,751 (1.1%) 25/3,493 (0.7%) 9/216 (4.2%)* 7/42 (16.7%)*† <0.001 
CKD progression at 3-month 13/3,665 (0.4%) 4/3,423 (0.1%)  3/207 (1.4%)* 6/35 (17.1%)*† <0.001 
1-year mortality 217/3,751 (5.8%) 174/3,493 (5.0%) 33/216 (15.3%)* 10/42 (23.8%)* <0.001 
CKD progression at 1-year 99/3,087 (3.2%) 74/2,902 (2.6%) 15/160 (9.4%)* 10/25 (40.0%)*† <0.001 
One patient still hospitalized at the time of data collection was excluded from the analyses of in-hospital mortality and hospital length of stay. 
Forty-one patients who died within 3 months after surgery and 45 patients with missing SCr data at 3 months after surgery were excluded from 
the analysis of CKD progression at 3 months. Additionally, 217 patients who died within 1 year after surgery and 447 patients with missing SCr 
data at 1 year after surgery were excluded from the analysis of CKD progression at 1 year. The median time [interquartile range] from the surgery 
to the evaluation of CKD progression at 3-month and 1-year was 17 [10–40] and 335 [298–366] days, respectively. Denominators indicate the 
total number of patients. Hospital length of stay was presented as median (95% confidence interval). *, P < 0.017 (significantly different with 
Bonferroni correction), compared to patients without AKI. †, P < 0.017 (significantly different with Bonferroni correction), compared to patients 
with transient AKI. AKI, acute kidney injury; CKD, chronic kidney disease. 
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Table 4. Multivariable Cox proportional hazard regression analysis assessing independent 
association between AKI type and mortality 
 Adjusted hazard ratio (95% CI) P-value 
AKI type   
   No AKI 1 (Reference)  
   Transient AKI 2.01 (1.34–2.93) 0.001 
   Persistent AKI 6.20 (3.00–11.43) <0.001 
Age (per 10 years) 1.37 (1.20–1.58) <0.001 
Male sex 1.11 (0.82–1.52) 0.502 
Hypertension 0.96 (0.71–1.29) 0.803 
Diabetes mellitus 1.26 (0.91–1.73) 0.154 
Chronic kidney disease 1.11 (0.78–1.54) 0.557 
Active congestive heart failure 1.84 (0.76–3.73) 0.160 
Type of surgery   
   Colorectal 1 (Reference)  
   Liver 1.64 (1.02–2.64) 0.039 
   Gastric 1.60 (0.96–2.67) 0.070 
   Pancreatic 2.72 (1.70–4.34) <0.001 
   Esophageal 3.70 (2.08–6.56) <0.001 
   Complex 8.42 (3.91–18.12) <0.001 
Emergency surgery 0.70 (0.04–3.24) 0.714 
Duration of surgery (per 1 h) 1.11 (1.06–1.17) <0.001 
Intraoperative blood loss (per 100 mL) 1.01 (1.01–1.02) <0.001 
The need for intraoperative vasopressor 
infusion 
1.14 (0.77–1.65) 0.512 
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Table 5. Multivariable logistic regression analysis assessing independent associations between 
AKI type and CKD progression at 1 year 
 Adjusted odds ratio (95% CI) P-value 
AKI type   
   No AKI 1 (Reference)  
   Transient AKI 3.87 (2.12–7.08) <0.001 
   Persistent AKI 23.70 (9.64–58.22) <0.001 
Age (per 10 years) 1.39 (1.14–1.70) <0.001 
Male sex 0.76 (0.49–1.18) 0.223 
Body mass index 0.96 (0.90–1.03) 0.239 
Hypertension 1.62 (1.02–2.56) 0.039 
Diabetes mellitus 1.54 (0.94–2.54) 0.086 
Active congestive heart failure 0.73 (0.16–3.30) 0.681 
Preoperative eGFR (per 10 mL/min/1.73 m2) 1.20 (1.10–1.32) <0.001 











Figure 2. Kaplan–Meier curve of patients without AKI, with transient AKI, or with persistent 
AKI. No AKI vs. Transient AKI: P < 0.001, No AKI vs. Persistent AKI: P < 0.001, Transient 











Supplementary Table 1. Association of AKI type and outcomes stratified by the maximal AKI stage 
 
Transient AKI Persistent AKI 
 Adjusted association P-value Adjusted association P-value 
Mortality     
   Stage 1 AKI 1.97 (1.32–2.96) <0.001 1.13 (0.16–8.16) 0.903 
   Stage 2–3 AKI 2.19 (0.69–6.96) 0.183 11.38 (5.61–23.08) <0.001 
CKD progression at 1 year     
   Stage 1 AKI 3.59 (1.86–6.93) <0.001 13.40 (4.21–42.70) <0.001 
   Stage 2–3 AKI 5.37 (1.44–20.00) 0.012 63.1 (13.6–293.0) <0.001 




Supplementary Table 2. Preoperative eGFR category and eGFR category at 1 year of patients demonstrating CKD progression at 1 year 
  
No AKI 
(n = 74) 
 
Transient AKI 
(n = 15) 
 
Persistent AKI 
(n = 10) 
Preoperative eGFR category 1 2 3a 3b 4 
 
1 2 3a 3b 4 
 
1 2 3a 3b 4 
eGFR category at 1 year 
                 
   2 26 - - - - 
 
1 - - - - 
 
2 - - - - 
   3a 1 27 - - - 
 
0 3 - - - 
 
1 2 - - - 
   3b 1 9 5 - - 
 
0 4 4 - - 
 
0 3 0 - - 
   4 0 1 0 2 - 
 
1 0 0 1 - 
 
1 0 0 0 - 
   5 0 0 0 0 2 
 
0 0 0 0 1 
 
0 0 0 0 1 
Most patients with CKD progression demonstrated worsening of eGFR by one eGFR category. The proportions of patients with no AKI, 
transient AKI and persistent AKI who demonstrated reduced eGFR level by ≥2 eGFR categories were 16.2%, 33.3%, and 50.0%, respectively. 
Four patients developed CKD stage 5 at 1 year. eGFR, estimated; AKI, acute kidney injury. 
 
 
